ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 65 filers reported holding ZS PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $525,000 | -92.3% | 8,000 | -93.9% | 0.10% | -84.5% |
| Q2 2015 | $6,847,000 | +19.9% | 130,700 | -3.7% | 0.64% | +19.7% |
| Q1 2015 | $5,710,000 | -2.2% | 135,700 | -3.4% | 0.54% | -3.8% |
| Q4 2014 | $5,841,000 | +3.8% | 140,500 | -2.0% | 0.56% | -3.6% |
| Q3 2014 | $5,626,000 | +22.3% | 143,400 | -10.4% | 0.58% | +47.1% |
| Q2 2014 | $4,600,000 | – | 160,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 2,576,723 | $169,188,000 | 84.73% |
| DAFNA Capital Management LLC | 66,194 | $4,346,000 | 4.31% |
| Opaleye Management Inc. | 95,000 | $6,238,000 | 3.07% |
| Redmile Group, LLC | 514,107 | $33,756,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,002,444 | $65,820,000 | 1.41% |
| MAZAMA CAPITAL MANAGEMENT INC | 76,779 | $5,041,000 | 1.05% |
| Kerrisdale Advisers, LLC | 45,021 | $2,956,000 | 0.86% |
| Rock Springs Capital Management LP | 155,000 | $10,177,000 | 0.83% |
| USS Investment Management Ltd | 590,396 | $38,765,000 | 0.69% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 21,479 | $1,410,000 | 0.67% |